MEDISPA.PRO
Ministry of Health code: A02.01.001.001 Axis M0 · Introductory check-up and longevity biomarkers CEBM: Level B (Functional diagnostics and check-up)

Bioimpedance body composition analysis

Bioelectrical Impedance Analysis (BIA)

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

To the procedure catalogue Equipment fleet Integration treatment rooms Rates and economics
Session duration
10 min
Turnover: ~30 min
Recommended course
1 sessions
1 treatments – an assumption for the economic calculation; the course is prescribed by a physician
Throughput capacity
16 pts
per 8-hour shift
Median rate
2 875 ₽
2 288 ₽ – 4 400 ₽
Course cost
2 875 ₽
at market median
Publication volume
Level B
5 publ. in PubMed

Clinical profile

Estimation of fat and fat-free mass from the electrical resistance of tissues. The method is quick and radiation-free but agrees poorly with densitometry (DXA): wide limits of agreement, overestimation of fat-free mass and underestimation of visceral fat. Suitable for tracking changes in one individual over time, not for precise diagnosis.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Where studies show an effect

  • Long-term monitoring of body composition in athletes without radiation exposure. [1]
  • Sarcopenia: under the EWGSOP2 consensus, once low muscle strength is identified, the diagnosis is confirmed by assessing muscle quantity and quality. [5]

Open questions and study limitations

  • Bioimpedance and DXA results are not interchangeable: bioimpedance overestimates fat-free mass, and the limits of agreement are wide. [1]
  • Visceral fat is systematically underestimated. [2]
  • The ASPEN 2020 guidelines make no recommendation on use in patients with disease: validity data are still scarce and manufacturers' equations are proprietary. [3]
  • Muscle mass can be estimated correctly only with an equation validated for that population and that device. [4]
Contraindications. Contraindications are determined by the physician according to the equipment or drug instructions; they are not given in study abstracts.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
Body composition analyser (bioimpedance)

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
ACCUNIQ BC720
Medical device, Roszdravnadzor registration certificate / CE
In the registry →
Body composition analyser (bioimpedance analysis)
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →
1.1.11 20.0 m² · Class V

Dietitian / nutritionist's room

Physicians' consulting and examination rooms · Equipment: 2 942 700 ₽

Treatment room passport →
1.2.1 25.0 m² · Class V

Functional diagnostics room

Diagnostic unit (functional, radiology, ultrasound diagnostics) · Equipment: 440 400 ₽

Treatment room passport →
HMI.BODY.06 12.0 m² · Class V

Anthropometry and bioimpedance analysis room

International flagship high-tech modalities · Equipment: 1 900 000 ₽

Treatment room passport →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 2 288 ₽
Market median 2 875 ₽
75th percentile (P75) 4 400 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 8 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

Systematic reviews comparing it with reference methods show limited accuracy; clinical guidelines are cautious.

Publication level B · Some data
  1. 1.
    Agreement Between Dual-Energy X-ray Absorptiometry and Bioelectric Impedance Analysis for Assessing Body Composition in Athletes: A Systematic Review and Meta-Analysis.
    Clin J Sport Med, 2023 · Systematic review and meta-analysis · PMID 36853902
    Athletes: bioimpedance overestimates fat-free mass relative to DXA, and the limits of agreement are wide; acceptable for long-term monitoring.
  2. 2.
    Intra-Abdominal Adipose Tissue Quantification by Alternative Versus Reference Methods: A Systematic Review and Meta-Analysis.
    Obesity (Silver Spring), 2019 · Systematic review and meta-analysis · PMID 31131996
    Visceral fat: bioimpedance systematically underestimates it compared with CT and MRI.
  3. 3.
    American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations.
    JPEN J Parenter Enteral Nutr, 2020 · ASPEN clinical guidelines · PMID 31216070
    No recommendation has yet been made for clinical populations: validity data are scarce.
  4. 4.
    Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review.
    Clin Nutr ESPEN, 2020 · Systematic review · PMID 31987121
    Estimating muscle mass requires an equation validated for the specific population and device.
  5. 5.
    Sarcopenia: revised European consensus on definition and diagnosis.
    Age Ageing, 2019 · EWGSOP2 consensus · PMID 30312372
    Sarcopenia: the key sign is low muscle strength; muscle quantity and quality confirm the diagnosis.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.